Droxidopa Capsule
Product Images NDC 70436-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 70436-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxidopa-structural-formula (Image 01)

FDA Label Image

Droxidopa-figure1 (Image 02)

FDA Label Image

Droxidopa-figure2 (Image 03)

Droxidopa-figure2 (Image 03)
This appears to be a graph showing the percentage of subjects who responded with either a better or worse improvement in OHSA Question 1 after taking either a placebo or droxidopa. The graph includes a y-axis with percentages ranging from -7% to 8% and an x-axis with a scale of 0 to 6. However, the context of the study or experiment is not available.*
FDA Label Image

70436-140-06 (Image 04)

FDA Label Image

70436-141-06 (Image 05)

FDA Label Image

70436-142-06 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.